Michael Nazak
Net worth: - $ as of 2024-04-29
Network origin in Michael Nazak first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 29 | |
| Public Company | Pharmaceuticals: Major | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Michael Nazak via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| ALZA CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Chief Tech/Sci/R&D Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing Chief Tech/Sci/R&D Officer | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Corporate Officer/Principal | |
MedImmune Vaccines, Inc.
 MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company is located in Mountain View, CA | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member Corporate Officer/Principal General Counsel | |
| INSMED INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| CAREDX, INC | Medical Specialties | Director of Finance/CFO | |
| HUMANIGEN, INC. | Biotechnology | Chairman Director/Board Member | |
InteKrin Therapeutics, Inc.
 InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| NGM BIOPHARMACEUTICALS, INC. | Biotechnology | Director of Finance/CFO | |
| RECEPTOS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SPYRE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Innocrin Pharmaceuticals Holdings LLC
 Innocrin Pharmaceuticals Holdings LLC Medical SpecialtiesHealth Technology Innocrin Pharmaceuticals Holdings LLC discovers and develops oral inhibitors for the treatment of Castration-Resistant Prostate Cancer (CRPC). The company is headquartered in Durham, NC. | Medical Specialties | Director/Board Member | |
| Boston University | College/University | Masters Business Admin Graduate Degree | |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | College/University | Doctorate Degree | |
| University of Toronto | College/University | Graduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree Corporate Officer/Principal | |
| University of California, Santa Barbara | College/University | Undergraduate Degree Undergraduate Degree | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| NEPHROGENEX INC | Medical Distributors | President | |
| PDL BIOPHARMA, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Strasbourg | College/University | Doctorate Degree | |
International School of The Peninsula
 International School of The Peninsula Other Consumer ServicesConsumer Services The International School of The Peninsula is an independent bilingual school located in Palo Alto and Menlo Park. The school offers the International Baccalaureate (IB) program and is considered the best in the area. | Other Consumer Services | Director/Board Member | |
Medpace Medical Device, Inc.
 Medpace Medical Device, Inc. Miscellaneous Commercial ServicesCommercial Services Medpace Medical Device, Inc. provides research and development services focusing on medical device clinical trials. The company is headquartered in Blaine, MN. | Miscellaneous Commercial Services | Chief Executive Officer | |
TriSalus Operating Life Sciences, Inc.
 TriSalus Operating Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology TriSalus Operating Life Sciences, Inc. develops infusion systems for the interventional radiology and oncology markets. Its infusion systems are designed to deliver embolic agents through a micro-catheter with an expandable tip that collapses in forward flow and expands the vessel wall in reverse flow to increase targeted delivery, minimize reflux, and reduce damage to healthy tissue. The company was founded by Aravind Arepally and James E. Chomas in 2011 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| Stephen M. Ross School of Business | College/University | Masters Business Admin | |
| DIADEXUS, INC. | Biotechnology | Director of Finance/CFO | |
Lilly Ventures Fund I LLC
 Lilly Ventures Fund I LLC Investment ManagersFinance Lilly Ventures Fund I LLC seeks investment opportunities located in the North American and European regions. The fund targets companies operating in the fields of biotechnology, medical technology and healthcare IT. It provides financing for early stage capital requirements. | Investment Managers | Corporate Officer/Principal | |
| Institut National Polytechnique de Lorraine | College/University | Undergraduate Degree | |
| MEDPACE HOLDINGS, INC. | Miscellaneous Commercial Services | Chief Executive Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Takeda Vaccines, Inc.
 Takeda Vaccines, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Vaccines, Inc. provides biological research and development services. The company is based in Bozeman, MT. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| JV Consulting | President | ||
LIB Therapeutics LLC
 LIB Therapeutics LLC Pharmaceuticals: MajorHealth Technology LIB Therapeutics LLC is a pharmaceutical company that manufactures medicinal products. The private company is based in Wilmington, DE. The company was founded by Evan A. Stein, August James Troendle. David A. Cory has been the CEO of the company since 2023. | Pharmaceuticals: Major | Founder | |
CinRx Pharma LLC
 CinRx Pharma LLC Pharmaceuticals: MajorHealth Technology CinRx Pharma LLC develops biopharmaceutical products. It provides therapeutics in a novel way that meets the modern paradigm of drug development. The company was founded by Jonathan L. Isaacsohn in 2015 and is headquartered in Cincinnati, OH. | Pharmaceuticals: Major | Chairman | |
RubrYc Therapeutics, Inc.
 RubrYc Therapeutics, Inc. BiotechnologyHealth Technology RubrYc Therapeutics, Inc. develops antibody therapy applications. Its products include RubrYc Discovery Engine, through which people can decode protein interactions through the integration of data and biological science. The company was founded in 2017 and is headquartered in San Carlos, CA. | Biotechnology | Director/Board Member | |
| CINCOR PHARMA, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Medpace UK Ltd.
 Medpace UK Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2005, Medpace UK Ltd. is a subsidiary of Medpace Holdings, Inc. The company is based in London, UK. The British company offers clinical pharmacology and laboratory services, which include central laboratory, bioanalytical, ECG core lab, and imaging core labs. | Miscellaneous Commercial Services | Director/Board Member | |
Comera Life Sciences, Inc.
 Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Comera Life Sciences Holdings, Inc., Comera Life Sciences, Inc. is a company that has developed a technology platform to transform the formulation of biotherapeutics for the benefit of patients. The company is based in Woburn, MA. Reform Biologics, a subsidiary of Comera Life Sciences, offers formulation development collaborations and product-specific licenses for a broad spectrum of protein-based therapeutics. The company's patented technology can extend product life-cycles, enable alternative dosing, and improve manufacturing efficiency for biopharmaceutical partners. Reform Biologics creates gentler therapies for fragile patients, including pediatric patients, by using their proprietary technology to transform intravenous drugs into subcutaneous injections, to reduce adverse reactions, and to improve drug stability. The company's goal is to enhance comfort, convenience, safety, and compliance so that patients living with debilitating diseases can experience a better life while treating their medical conditions. The company was founded by David S. Soane, Zachariah Jonasson, and Jeffrey S Hackman has been the CEO of the company since 2021. Comera Life Sciences was acquired by OTR Acquisition Corp. on May 20, 2022 for $156.08 million. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| COMERA LIFE SCIENCES HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| TRISALUS LIFE SCIENCES, INC. | Medical Specialties | Chairman Chief Executive Officer | |
Innocrin Pharmaceuticals, Inc.
 Innocrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Innocrin Pharmaceuticals, Inc. develops oral inhibitors for the treatment of castration-resistant prostate cancer. It develops small molecule CYP17 lyase-selective inhibitors to treat resistant hormonally-dependent breast and prostate cancers. The firm’s product under pipeline is VT-464, a dual mechanism lyase-selective CYP17 inhibitor and androgen receptor (AR) antagonist that disrupts the validated biochemical pathways required for prostate cancer growth androgen biosynthesis and AR transcriptional signaling. The company was founded in 2004 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
| United States | 46 |
| France | 3 |
| Israel | 2 |
| Canada | 2 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 32 |
| Consumer Services | 13 |
| Commercial Services | 5 |
| Distribution Services | 2 |
| Finance | 2 |
Operational
| Director/Board Member | 155 |
| Corporate Officer/Principal | 97 |
| Independent Dir/Board Member | 47 |
| Chief Executive Officer | 28 |
| Chairman | 27 |
Most connected contacts
| Insiders | |
|---|---|
| James Healy | 50 |
| Ali Satvat | 28 |
| Mats Wahlström | 22 |
| Graham K. Crooke | 21 |
| V. Lawlis | 21 |
| S. Torres | 21 |
| Susan Windham-Bannister | 20 |
| Stephen Glover | 19 |
| Mary Szela | 19 |
| August Troendle | 16 |
| Barbara Finck | 15 |
| Jean-Frédéric Viret | 13 |
| Matthew R. Hooper | 12 |
| Fred Kurland | 11 |
| Aaron Schuchart | 10 |
- Stock Market
- Insiders
- Michael Nazak
- Company connections
